Lower Cost of Conducting Clinical Trials will Drive Growth
10-Mar-2015
Latin America
Market Research
P849-01-00-00-00
LS00144-LA-MR_16985
This research service presents an overview and analysis of the Latin American Contract Research Organization (CRO) market with a focus on Argentina, Brazil, and Mexico. It provides country revenue by phase, therapeutic type, and region. The study discusses key challenges and emerging market trends, while providing detailed information on support services such as central laboratory services. It also outlines market drivers and restraints, market engineering measurements, and research and development trends. The study covers the CRO industry’s complete life cycle from phase I trials to post-marketing surveillance, and also highlights emerging trends and their importance in current and future market scenarios.
Key Findings—LATAM
Key Findings—LATAM (continued)
Key Findings—LATAM (continued)
Key Findings—LATAM (continued)
Key Findings—LATAM (continued)
Key Findings—LATAM (continued)
Market Size Estimation Methodology
Scope and Segmentation
Key Questions this Study will Answer
Market Engineering Measurements—LATAM
CEO’s Perspective
Key Companies to Watch
3 Big Predictions
Market Perspective—LATAM
CRO Market Landscape—LATAM
CRO Market Attractiveness by Phase—LATAM
Porter’s Five Forces Analysis for the LATAM CRO Market
CRO Product Development & Commercialization
Market Segmentation—By Stages of Clinical Development
Key Findings—Argentina
Pharmaceutical Market Overview—Argentina
Pharmaceutical Market Overview—Argentina (continued)
Pharmaceutical Market Overview—Argentina (continued)
Pharmaceutical Market Overview—Argentina (continued)
Market Perspective—Argentina
CRO Market Landscape—Argentina
Clinical Trials Market Overview—Argentina
Clinical Trials Market Revenue Forecast—Argentina
Clinical Trials Market Revenue Forecast Discussion—Argentina
Profiles of Clinical Trials—Argentina
Profiles of Clinical Trials—Argentina (continued)
Clinical Trials Scenario—Argentina
Clinical Trials Scenario—Argentina (continued)
Clinical Trials Sponsorship—Argentina
Drivers and Restraints—Argentina
Drivers Explained—Argentina
Drivers Explained—Argentina (continued)
Restraints Explained—Argentina
Restraints Explained—Argentina (continued)
Forecast Assumptions
Market Engineering Measurements—Argentina
Argentina CRO Market—Revenue Forecast
Argentina CRO Market—Revenue Forecast Discussion
CRO Market Snapshot—Argentina
Argentina CRO Market—Phase I & Phase II
Argentina CRO Market—Phase III & Late Phase
Argentina CRO Market—Data Management
Argentina CRO Market—Data Management (continued)
Argentina CRO Market—Biostatistics
Argentina CRO Market—Biostatistics(continued)
Argentina CRO Market—Central Laboratory Services
Argentina CRO Market—Central Laboratory Services (continued)
Argentina CRO Market—Health Economics and Outcomes Research (HEOR)
Argentina CRO Market—Health Economics and Outcomes Research (continued)
Argentina CRO Market—Pharmacovigilance
Argentina CRO Market—Pharmacovigilance (continued)
Argentina CRO Market—Postmarketing Surveillance
Argentina CRO Market—Postmarketing Surveillance (continued)
Argentina CRO Market Segmentation—By Stages of Clinical Development
Key Market Trends—Argentina
Clinical Research Regulatory Overview—Argentina
Clinical Research Regulatory Process—Argentina
Clinical Research Regulatory Process—Argentina (continued)
Clinical Research Regulatory Process—Argentina (continued)
Competitive Analysis—Argentina
Market Share Analysis—Argentina
Competitive Structure—Argentina
Competitive Analysis—Selected Key Market Participants
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Key Findings—Brazil
Pharmaceutical Market Overview—Brazil
Pharmaceutical Market Overview—Brazil (continued)
Pharmaceutical Market Overview—Brazil (continued)
Pharmaceutical Market Overview—Brazil (continued)
Pharmaceutical Market Overview—Brazil (continued)
Pharmaceutical Market Overview—Brazil (continued)
Market Perspective—Brazil
CRO Market Landscape—Brazil
Clinical Trials Market Overview—Brazil
Clinical Trials Market Revenue Forecast—Brazil
Clinical Trials Market Revenue Forecast Discussion—Brazil
Profiles of Clinical Trials—Brazil
Profiles of Clinical Trials—Brazil (continued)
Clinical Trials Scenario—Brazil
Clinical Trials Scenario—Brazil (continued)
Clinical Trials Sponsorship—Brazil
Drivers and Restraints—Brazil
Drivers Explained—Brazil
Drivers Explained—Brazil (continued)
Drivers Explained—Brazil (continued)
Restraints Explained—Brazil
Restraints Explained—Brazil (continued)
Forecast Assumptions
Market Engineering Measurements—Brazil
Brazil CRO Market—Revenue Forecast
Brazil CRO Market—Revenue Forecast Discussion
CRO Market Snapshot—Brazil
Brazil CRO Market—Phase I & Phase II
Brazil CRO Market—Phase III & Late Phase
Brazil CRO Market—Data Management
Brazil CRO Market—Data Management (continued)
Brazil CRO Market—Biostatistics
Brazil CRO Market—Biostatistics (continued)
Brazil CRO Market—Central Laboratory Services
Brazil CRO Market—Central Laboratory Services (continued)
Brazil CRO Market—Health Economics and Outcomes Research (HEOR)
Brazil CRO Market—Health Economics and Outcomes Research (continued)
Brazil CRO Market—Pharmacovigilance
Brazil CRO Market—Pharmacovigilance (continued)
Brazil CRO Market—Postmarketing Surveillance
Brazil CRO Market—Postmarketing Surveillance (continued)
Brazil CRO Market Segmentation—By Stages of Clinical Development
Key Market Trends—Brazil
Clinical Research Regulatory Overview—Brazil
Clinical Research Regulatory Overview—Brazil (continued)
Clinical Research Regulatory Overview—Brazil (continued)
Clinical Research Regulatory Process—Brazil
Competitive Analysis—Brazil
Market Share Analysis—Brazil
Competitive Structure—Brazil
Competitive Analysis—Selected Key Market Participants
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Key Findings—Mexico
Pharmaceutical Market Overview—Mexico
Pharmaceutical Market Overview—Mexico (continued)
Pharmaceutical Market Overview—Mexico (continued)
Pharmaceutical Market Overview—Mexico (continued)
Pharmaceutical Market Overview—Mexico (continued)
Market Perspective—Mexico
CRO Market Landscape—Mexico
Clinical Trials Market Overview—Mexico
Clinical Trials Market Revenue Forecast—Mexico
Clinical Trials Market Revenue Forecast Discussion—Mexico
Profiles of Clinical Trials—Mexico
Profiles of Clinical Trials—Mexico (continued)
Clinical Trials Scenario—Mexico
Clinical Trials Scenario—Mexico (continued)
Clinical Trials Sponsorship—Mexico
Drivers and Restraints—Mexico
Drivers Explained—Mexico
Drivers Explained—Mexico (continued)
Restraints Explained—Mexico
Restraints Explained—Mexico (continued)
Forecast Assumptions
Market Engineering Measurements—Mexico
Mexico CRO Market—Revenue Forecast
Mexico CRO Market—Revenue Forecast Discussion
CRO Market Snapshot—Mexico
Mexico CRO Market—Phase I & Phase II
Mexico CRO Market—Phase IIII & Late Phase
Mexico CRO Market—Data Management
Mexico CRO Market—Data Management (continued)
Mexico CRO Market—Biostatistics
Mexico CRO Market—Biostatistics (continued)
Mexico CRO Market—Central Laboratory Services
Mexico CRO Market—Central Laboratory Services (continued)
Mexico CRO Market—Health Economics and Outcomes Research (HEOR)
Mexico CRO Market—Health Economics and Outcomes Research (continued)
Mexico CRO Market—Pharmacovigilance
Mexico CRO Market—Pharmacovigilance (continued)
Mexico CRO Market—Postmarketing Surveillance
Mexico CRO Market—Postmarketing Surveillance (continued)
Mexico CRO Market Segmentation—By Stages of Clinical Development
Key Market Trends—Mexico
Clinical Research Regulatory Overview—Mexico
Clinical Research Regulatory Overview—Mexico (continued)
Clinical Research Regulatory Overview—Mexico (continued)
Clinical Research Regulatory Process—Mexico
Competitive Analysis—Mexico
Market Share Analysis—Mexico
Competitive Structure—Mexico
Competitive Analysis—Selected Key Market Participants
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
3 Big Predictions
The Last Word—Discussion
Legal Disclaimer
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
Market Engineering Methodology
Learn More—Next Steps
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Rita Ragazzi |
| WIP Number | P849-01-00-00-00 |
| Is Prebook | No |
Latin American Contract Research Organization Market
$3,950.00
Special Price $2,962.50 save 25 %